Recruiting
Squamous cell carcinoma of head and neck+7
RecruitingRegistered drugNo placebo
Study on PET Imaging with Fianlimab and Cemiplimab for Patients with Advanced Solid Tumors, with or without Platinum-Based Chemotherapy
Registered drugNo placebo
- Disease:Squamous cell carcinoma of head and neckMicrosatellite instability cancer+6
- Substances:CemiplimabFianlimab
Countries:
The Netherlands
The Netherlands- Participants:18–64 years · 65+ years
- Substances:Cemiplimab
- Sponsor:Universitair Medisch Centrum Groningen




